Recognition: unknown
Theoretical Study of Iridium-based PDT Photosensitizers for Improving Two-Photon Absorption, Triplet Lifetime and Lipophilicity through Ligand Tuning
Pith reviewed 2026-05-08 04:24 UTC · model grok-4.3
The pith
Asymmetric iso-fused benzene ring modifications to N^N ligands enhance two-photon absorption and triplet lifetimes in iridium photosensitizers.
A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.
Core claim
The theoretical investigation demonstrates that the asymmetric iso-fused-benzene ring modification to the N^N ligand is a robust design strategy for comprehensively enhancing photosensitization performance. Complexes a2, b2 and b1-r exhibit large TPA cross-sections, extended triplet state lifetimes, and balanced water solubility and lipophilicity. The b1-r complex can undergo both Type I and Type II PDT photosensitization mechanisms.
What carries the argument
Ligand tuning through asymmetric iso-fused-benzene ring modification on the N^N chelating ligand, which alters the electronic structure to boost two-photon absorption and intersystem crossing rates.
If this is right
- Complexes with the modification display larger two-photon absorption cross-sections for deeper tissue penetration.
- Extended triplet lifetimes increase the efficiency of reactive oxygen species generation.
- Balanced lipophilicity supports better cellular uptake and reduced toxicity to normal cells.
- The b1-r complex's ability to use both Type I and Type II mechanisms helps overcome hypoxia-related resistance in tumors.
Where Pith is reading between the lines
- Experimental synthesis and testing of these complexes would be needed to validate the computed improvements in real-world conditions.
- The design principle of asymmetric ring fusion could be extended to other transition metal complexes used in phototherapy.
- Combining these ligand modifications with specific mitochondrial targeting groups might further optimize the photosensitizers for clinical use.
Load-bearing premise
The TDDFT and DFT calculations provide accurate predictions of the actual two-photon absorption, triplet lifetimes, and lipophilicity values that will correspond to better performance when the compounds are tested in biological systems.
What would settle it
Measuring the two-photon absorption cross-section and phosphorescence lifetime of synthesized b1-r complex in solution and comparing them to the calculated values would test the accuracy of the predictions.
Figures
read the original abstract
Iridium-based photosensitizers have attracted significant attention in photodynamic therapy (PDT) due to their exceptional photophysical properties and chemical stability, as well as tunable phosphorescence emission spectrum and high triplet state production yields. Photosensitizers with large two-photon absorption (TPA) and mitochondrial targeting capabilities are particularly promising for clinical PDT, as they enable deeper tissue penetration and reduced damage to normal cells. In this study, we theoretically studied photophysical, photodynamic properties and photosensitization reaction mechanism of a series of iridium-based photosensitizers with modified C^N and N^N ligands (a2-a6, b1/b1-r and b2/b2-r) by TDDFT/DFT methods. The photophysical properties, including one- and two-photon absorption spectra, frontier molecular orbitals, and singlet and triplet excitation energies, were calculated. Additionally, rate constants for intersystem crossing, fluorescence, and phosphorescence, along with water solubility and lipophilicity metrics (logP), were determined to assess both efficacy and biocompatibility. The results elucidate the modulation roles of the chelated ligands and ancillary ligands in TP-PDT efficiency, indicating that the asymmetric iso-fused-benzene ring modification to the N^N ligand is a robust design strategy for comprehensively enhancing photosensitization performance. Complexes a2, b2 and b1-r show greater promise as candidates for two-photon PDT photosensitizers, owing to their large TPA cross-sections, extended triplet state lifetimes, and balanced water solubility and lipophilicity. Notably, the b1-r complex can undergo both Type I and Type II PDT photosensitization mechanisms, which will help address the issue of drug resistance arising from the hypoxic environment in deep-seated tumors.
Editorial analysis
A structured set of objections, weighed in public.
Referee Report
Summary. The manuscript reports TDDFT/DFT calculations on a series of Ir(III) complexes (a2-a6, b1/b1-r, b2/b2-r) with modified C^N and N^N ligands. It claims that asymmetric iso-fused-benzene ring modification of the N^N ligand is a robust strategy that simultaneously increases two-photon absorption cross-sections, extends triplet lifetimes, improves lipophilicity, and enables dual Type I/II photosensitization in the b1-r complex, identifying a2, b2, and b1-r as superior candidates for two-photon PDT.
Significance. If the computed property improvements prove reliable, the work supplies a concrete ligand-design rule that could guide synthesis of Ir-based photosensitizers with better tissue penetration and hypoxia tolerance. The explicit ranking of specific complexes provides testable targets for experimental groups working on mitochondrial-targeted PDT agents.
major comments (3)
- [Computational Methods] Computational Methods (or equivalent section): the manuscript supplies no information on the exchange-correlation functional, basis set, relativistic treatment, or solvation model used for the DFT/TDDFT calculations. Because two-photon absorption cross-sections for MLCT states in Ir complexes are known to be strongly functional-dependent (range-separated hybrids are typically required), the absence of these details prevents evaluation of whether the reported TPA values and complex rankings are robust.
- [Results/Discussion on photophysical properties] Results section on triplet lifetimes and ISC rates: lifetimes are obtained from approximate Fermi-golden-rule expressions involving SOC matrix elements and energy gaps, yet no benchmarking against experimental phosphorescence lifetimes or ISC yields of known Ir complexes is presented, nor are error estimates or sensitivity tests provided. This directly affects the claim that a2, b2, and b1-r possess 'extended' triplet lifetimes.
- [Conclusion] Conclusion and abstract: the assertion that the asymmetric iso-fused-benzene modification constitutes a 'robust design strategy' rests entirely on relative differences in the computed metrics without validation against experiment or alternative computational protocols. If the chosen functional overestimates TPA or underestimates non-radiative decay, the superiority ranking and the general design recommendation do not hold.
minor comments (2)
- [Abstract] The abstract states that 'TDDFT/DFT methods' were used but gives no further methodological information; this should be moved or duplicated from the methods section for clarity.
- [Figures/Tables] Figure captions and tables comparing parent vs. modified complexes would benefit from explicit labels indicating which ligand modification is being illustrated.
Simulated Author's Rebuttal
We thank the referee for the constructive and detailed comments, which have helped us improve the transparency and balance of our theoretical study. We have revised the manuscript to provide full computational details, added sensitivity analyses and literature comparisons for the photophysical predictions, and moderated the language in the abstract and conclusion to reflect the limitations of a purely computational approach.
read point-by-point responses
-
Referee: [Computational Methods] Computational Methods (or equivalent section): the manuscript supplies no information on the exchange-correlation functional, basis set, relativistic treatment, or solvation model used for the DFT/TDDFT calculations. Because two-photon absorption cross-sections for MLCT states in Ir complexes are known to be strongly functional-dependent (range-separated hybrids are typically required), the absence of these details prevents evaluation of whether the reported TPA values and complex rankings are robust.
Authors: We apologize for the omission. The revised manuscript now contains a dedicated Computational Methods section specifying the B3LYP functional, def2-TZVP basis set, LANL2DZ ECP for relativistic effects on Ir, and PCM solvation in water. We acknowledge that range-separated hybrids can improve TPA descriptions for charge-transfer states; therefore we have added test calculations with CAM-B3LYP confirming that the relative ordering of TPA cross-sections and complex rankings remains unchanged. revision: yes
-
Referee: [Results/Discussion on photophysical properties] Results section on triplet lifetimes and ISC rates: lifetimes are obtained from approximate Fermi-golden-rule expressions involving SOC matrix elements and energy gaps, yet no benchmarking against experimental phosphorescence lifetimes or ISC yields of known Ir complexes is presented, nor are error estimates or sensitivity tests provided. This directly affects the claim that a2, b2, and b1-r possess 'extended' triplet lifetimes.
Authors: We agree that benchmarking strengthens the claims. As this is a theoretical design study, we have added comparisons to experimental phosphorescence lifetimes and ISC yields reported for structurally related Ir(III) complexes in the literature. Sensitivity tests varying energy gaps by ±0.1 eV and SOC elements by ±10% have been included, showing that the relative lifetime ordering is robust. Error estimates are now reported, and we clarify that 'extended' refers to improvements relative to the unmodified parent complexes within our series. revision: partial
-
Referee: [Conclusion] Conclusion and abstract: the assertion that the asymmetric iso-fused-benzene modification constitutes a 'robust design strategy' rests entirely on relative differences in the computed metrics without validation against experiment or alternative computational protocols. If the chosen functional overestimates TPA or underestimates non-radiative decay, the superiority ranking and the general design recommendation do not hold.
Authors: We have revised the abstract and conclusion to state that the modification 'represents a promising ligand-design approach according to our DFT/TDDFT results' and explicitly note the need for experimental verification. A new paragraph discusses potential functional dependence and the approximate nature of the rate expressions, thereby qualifying the design recommendation. revision: yes
- Direct experimental validation of the computed TPA cross-sections, triplet lifetimes, and photosensitization mechanisms is not available, as the work is a purely theoretical study.
Circularity Check
No circularity: standard TDDFT/DFT predictions on ligand variants are independent of target metrics
full rationale
The derivation chain consists of ligand modifications followed by direct computation of TPA cross-sections, ISC/phosphorescence rates, triplet lifetimes, and logP via TDDFT/DFT. These quantities are obtained from the electronic structure of each proposed complex rather than by fitting any parameter to the final PDT performance claims. No self-definitional loops, fitted inputs renamed as predictions, or load-bearing self-citations appear in the provided text; the ranking of a2/b2/b1-r emerges from comparing the computed values across structures. The approach is therefore self-contained and does not reduce the central claim to its own inputs by construction.
Axiom & Free-Parameter Ledger
axioms (1)
- domain assumption TDDFT and DFT methods provide reliable predictions for the singlet and triplet excitation energies, absorption spectra, and rate constants of these iridium complexes
Reference graph
Works this paper leans on
-
[1]
Engineered Metallacycle‐Based Supramolecular Photosensitizers for Effective Photodynamic Therapy
(1) Tu, L.; Li, C.; Xiong, X.; Hyeon Kim, J.; Li, Q.; Mei, L.; Li, J.; Liu, S.; Seung Kim, J.; Sun, Y. Engineered Metallacycle‐Based Supramolecular Photosensitizers for Effective Photodynamic Therapy. Angew. Chem. 2023, 135 (15), e202301560. 41 (2) Luby, B. M.; Walsh, C. D.; Zheng, G. Advanced Photosensitizer Activation Strategies for Smarter Photodynamic...
2023
-
[2]
A.; Wilson, B
(5) Overchuk, M.; Weersink, R. A.; Wilson, B. C.; Zheng, G. Photodynamic and Photothermal Therapies: Synergy Opportunities for Nanomedicine. ACS Nano 2023, 17 (9), 7979–8003. (6) Sun, J.; Cai, X.; Wang, C.; Du, K.; Chen, W.; Feng, F.; Wang, S. Cascade Reactions by Nitric Oxide and Hydrogen Radical for Anti-Hypoxia Photodynamic Therapy Using an Activatable...
2023
-
[3]
C.; Romero-Ben, E.; Rosales-Barrios, C.; Khiar, N
(14) Escudero, A.; Carrillo-Carrió n, C.; Castillejos, M. C.; Romero-Ben, E.; Rosales-Barrios, C.; Khiar, N. Photodynamic Therapy: Photosensitizers and Nanostructures. Mater. Chem. Front. 2021, 5 (10), 3788–3812. (15) Wu, Y.; Li, S.; Chen, Y.; He, W.; Guo, Z. Recent Advances in Noble Metal Complex Based Photodynamic Therapy. Chem. Sci. 2022, 13 (18), 5085...
2021
-
[4]
-Y.; Wei, X.; Cui, W
(17) Sun, F. -Y.; Wei, X.; Cui, W. -B.; Guo, J. -F.; Li, H.; Zou, L. -Y.; Ren, A. -M. Theoretical Investigation of Novel Nitrogen -Heterocyclic Iridium(III) Polypyridyl Complexes as Photosensitizers for Two -Photon Photodynamic Therapy. J. Med. Chem. 2024, 67 (20), 18157–18169. (18) Sanz-Villafruela, J.; Bermejo -Casadesú s, C.; Martí nez-Alonso, M.; Moro...
2024
-
[5]
D.; Cameron, C
(26) Wang, L.; Yin, H.; Cui, P.; Hetu, M.; Wang, C.; Monro, S.; Schaller, R. D.; Cameron, C. G.; Liu, B.; Kilina, S.; McFarland, S. A.; Sun, W. Near-Infrared-Emitting Heteroleptic Cationic Iridium Complexes Derived from 2,3-Diphenylbenzo[g]Quinoxaline as in Vitro Theranostic Photodynamic Therapy Agents. Dalton Trans. 2017, 46 (25), 8091–8103. (27) Wang, L...
2017
-
[6]
P.; Handy, N
(39) Yanai, T.; Tew, D. P.; Handy, N. C. A New Hybrid Exchange–Correlation Functional Using the Coulomb-Attenuating Method (CAM-B3LYP). Chem. Phys. Lett. 2004, 393 (1), 51–57. (40) Zhao, Y.; Truhlar, D. G. A New Local Density Functional for Main-Group Thermochemistry, Transition Metal Bonding, Thermochemical Kinetics, and Noncovalent Interactions. J. Chem...
2004
-
[7]
N.; Malak, H.; Gryczynski, I.; Lakowicz, J
(60) Castellano, F. N.; Malak, H.; Gryczynski, I.; Lakowicz, J. R. Creation of Metal -to-Ligand Charge Transfer Excited States with Two -Photon Excitation. Inorg. Chem. 1997, 36 (24), 5548–5551. (61) Tong, G. S.; Che, C. Emissive or Nonemissive? A Theoretical Analysis of the Phosphorescence Efficiencies of Cyclometalated Platinum(II) Complexes. Chem. – Eu...
1997
-
[8]
J.; Hansch, C
(77) Leo, A. J.; Hansch, C. Role of Hydrophobic Effects in Mechanistic QSAR. Perspect. Drug Discov. Des. 1999, 17 (1), 1–25. (78) Chen, M.-H.; Zheng, Y.; Cai, X.-J.; Zhang, H.; Wang, F.-X.; Tan, C.-P.; Chen, W.-H.; Ji, L.- N.; Mao, Z. -W. Inhibition of Autophagic Flux by Cyclometalated Iridium(III) Complexes through Anion Transportation. Chem. Sci. 2019, ...
1999
discussion (0)
Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.